Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRCA1 and BRCA2 mutations and treatment strategies for breast cancer
Inês Godet, Daniele M. Gilkes
Integrative Cancer Science and Therapeutics (2017) Vol. 4, Iss. 1
Open Access | Times Cited: 223

Showing 1-25 of 223 citing articles:

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balázs Győrffy
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 4101-4109
Open Access | Times Cited: 1356
<p>Epidemiological characteristics of and risk factors for breast cancer in the world</p>
Zohre Momenimovahed, Hamid Salehiniya
Breast Cancer Targets and Therapy (2019) Vol. Volume 11, pp. 151-164
Open Access | Times Cited: 693
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
Daniela Miricescu, Alexandra Totan, Iulia-Ioana Stănescu-Spînu, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 173-173
Open Access | Times Cited: 564
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 515
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Laura Cortesi, Hope S. Rugo, Christian Jackisch
Targeted Oncology (2021) Vol. 16, Iss. 3, pp. 255-282
Open Access | Times Cited: 302
Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
Claudia Ceci, Pedro Miguel Lacal, Lucio Tentori, et al.
Nutrients (2018) Vol. 10, Iss. 11, pp. 1756-1756
Open Access | Times Cited: 214
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Ielizaveta Gorodetska, Iryna Kozeretska, Anna Dubrovska
Journal of Cancer (2019) Vol. 10, Iss. 9, pp. 2109-2127
Open Access | Times Cited: 184
Advanced Approaches to Breast Cancer Classification and Diagnosis
M. Zubair, S. Wang, Nawab Ali
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 162
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Léa Clusan, François Ferrière, Gilles Flouriot, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6834-6834
Open Access | Times Cited: 159
RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
Marco Infante, Alessandra Fabi, Francesco Cognetti, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 154
The Burden of Cancer, Government Strategic Policies, and Challenges in Pakistan: A Comprehensive Review
Anwar Ali, Muhammad Faisal Manzoor, Naz̲īr Aḥmad, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 83
Breast cancer in the era of precision medicine
Negar Sarhangi, Shahrzad Hajjari, Seyede Fatemeh Heydari, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 10, pp. 10023-10037
Closed Access | Times Cited: 72
Biomarkers in Breast Cancer: An Old Story with a New End
Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1364-1364
Open Access | Times Cited: 50
Triple-negative breast cancer: epidemiology, molecular mechanisms, and modern vaccine-based treatment strategies
Asad Mustafa Karim, Jeong Eun Kwon, Tanveer Ali, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115545-115545
Closed Access | Times Cited: 48
Recent advancements in nanomaterial-based biosensors for diagnosis of breast cancer: a comprehensive review
Yalda Yazdani, Fereshtehsadat Jalali, Habib Tahmasbi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer
Shridhar Pattar, Shakeel Ahamed Adhoni, Chandrappa M. Kamanavalli, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 105
Breast cancer, screening and diagnostic tools: All you need to know
Diego Barba, Ariana León-Sosa, Paulina Lugo, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 157, pp. 103174-103174
Open Access | Times Cited: 104
Graphene-Coated Optical Fiber SPR Biosensor for BRCA1 and BRCA2 Breast Cancer Biomarker Detection: a Numerical Design-Based Analysis
Md. Biplob Hossain, Md. Muztahidul Islam, Lway Faisal Abdulrazak, et al.
Photonic Sensors (2019) Vol. 10, Iss. 1, pp. 67-79
Open Access | Times Cited: 83
A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer
Vetriselvan Subramaniyan, Shivkanya Fuloria, Gaurav Gupta, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109735-109735
Closed Access | Times Cited: 72
The progress of multimodal imaging combination and subregion based radiomics research of cancers
Luyuan Zhang, Yumin Wang, Zhouying Peng, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3458-3469
Open Access | Times Cited: 39
Triple-Negative Breast Cancer: Molecular Particularities Still a Challenge
Vlad Bogdan Varzaru, Tania Vlad, Roxana Popescu, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1875-1875
Open Access | Times Cited: 14
A comprehensive review on the applications of ferrite nanoparticles in the diagnosis and treatment of breast cancer
Muhammad Furqan Akhtar, Aysha Afzaal, Ammara Saleem, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 12
BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review
Parvin Pourmasoumi, Ali Moradi, Mohammad Bayat
Reproductive Sciences (2024)
Closed Access | Times Cited: 9
Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice
Míriam Potrony, Blai Morales‐Romero, Lorena Moreno, et al.
Breast Cancer Research and Treatment (2025)
Closed Access | Times Cited: 1
Electrochemical DNA biosensors for label-free breast cancer gene marker detection
Mehmet Şenel, Muamer Dervisevic, Firdevs Kokkokoğlu
Analytical and Bioanalytical Chemistry (2019) Vol. 411, Iss. 13, pp. 2925-2935
Closed Access | Times Cited: 61
Page 1 - Next Page

Scroll to top